MA07.05 Phase 1b/2 Study of Combined HER Inhibition in Refractory EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)

Authors
Category Primary study
JournalJournal of Thoracic Oncology
Year 2022
This article has no abstract
Epistemonikos ID: 4ef7d1811f85a61071d32d27bbde47169f929be0
First added on: Feb 15, 2025